BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 16357309)

  • 1. Glycoprotein Ibalpha-mediated platelet adhesion and aggregation to immobilized thrombin under conditions of flow.
    Weeterings C; Adelmeijer J; Myles T; de Groot PG; Lisman T
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):670-5. PubMed ID: 16357309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation.
    Dumas JJ; Kumar R; Seehra J; Somers WS; Mosyak L
    Science; 2003 Jul; 301(5630):222-6. PubMed ID: 12855811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist.
    Berny MA; White TC; Tucker EI; Bush-Pelc LA; Di Cera E; Gruber A; McCarty OJ
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):329-34. PubMed ID: 17962622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ristocetin- and thrombin-induced platelet aggregation at physiological shear rates: differential roles for GPIb and GPIIb-IIIa receptor.
    Kasirer-Friede A; Frojmovic MM
    Thromb Haemost; 1998 Sep; 80(3):428-36. PubMed ID: 9759623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2'.
    Pennings MT; Derksen RH; van Lummel M; Adelmeijer J; VanHoorelbeke K; Urbanus RT; Lisman T; de Groot PG
    J Thromb Haemost; 2007 Feb; 5(2):369-77. PubMed ID: 17096706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the interaction between thrombin exosite 1 and the sequence 269-287 [correction of 269-297] of platelet glycoprotein Ibalpha.
    Bouton MC; Thurieau C; Guillin MC; Jandrot-Perrus M
    Thromb Haemost; 1998 Aug; 80(2):310-5. PubMed ID: 9716158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of thrombin with blood platelets.
    Lundblad RL; White GC
    Platelets; 2005 Nov; 16(7):373-85. PubMed ID: 16236598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of platelet-dependent fibrin formation in a patient with Scott syndrome.
    Wielders SJ; Broers J; ten Cate H; Collins PW; Bevers EM; Lindhout T
    Thromb Haemost; 2009 Jul; 102(1):76-82. PubMed ID: 19572071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V.
    Shi T; Giannakopoulos B; Yan X; Yu P; Berndt MC; Andrews RK; Rivera J; Iverson GM; Cockerill KA; Linnik MD; Krilis SA
    Arthritis Rheum; 2006 Aug; 54(8):2558-67. PubMed ID: 16868978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
    Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L
    Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shear induces a unique series of morphological changes in translocating platelets: effects of morphology on translocation dynamics.
    Maxwell MJ; Dopheide SM; Turner SJ; Jackson SP
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):663-9. PubMed ID: 16385083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A serine-rich glycoprotein of Streptococcus sanguis mediates adhesion to platelets via GPIb.
    Plummer C; Wu H; Kerrigan SW; Meade G; Cox D; Ian Douglas CW
    Br J Haematol; 2005 Apr; 129(1):101-9. PubMed ID: 15801962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of activated integrin alpha2beta1 in the firm adhesion of platelets onto a surface of immobilized collagen under flow conditions.
    Moroi M; Onitsuka I; Imaizumi T; Jung SM
    Thromb Haemost; 2000 May; 83(5):769-76. PubMed ID: 10823276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet membrane glycoproteins in haemostasis.
    Thomas S
    Clin Lab; 2002; 48(5-6):247-62. PubMed ID: 12071575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?
    Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L
    Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-induced conversion of fibrinogen to fibrin results in rapid platelet trapping which is not dependent on platelet activation or GPIb.
    Jarvis GE; Atkinson BT; Frampton J; Watson SP
    Br J Pharmacol; 2003 Feb; 138(4):574-83. PubMed ID: 12598411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.